Kazuhiko Sawada

Prof. Kazuhiko Sawada

Department of Nutrition, Faculty of Medical and Health Sciences, Tsukuba International University
orcid

Research Focus & Metrics

Academic Career Length

27Years (2000-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
8 September 2004 in Acta Neuropathologica
Verified
Journal Article
Closed access
HSHiromi Sakata-Haga
Hiromi Sakata-Haga
KSKazuhiko Sawada
Kazuhiko Sawada
TOTakamasa Ohnishi
Takamasa Ohnishi
YFYoshihiro Fukui
Yoshihiro Fukui

1 January 2014 in Neuroscience
Verified
Journal Article
Closed access
KSKazuhiko Sawada
Kazuhiko Sawada
KHK. Hikishima
K. Hikishima
AMA.Y. Murayama
A.Y. Murayama
HOHirotaka James Okano
Hirotaka James Okano
ESE. Sasaki
E. Sasaki
Hideyuki OkanoHideyuki Okano
Hideyuki Okano

28 October 2006 in Brain Structure and Function
Verified
Journal Article
Closed access
PDF file
KFK. Fukunishi
K. Fukunishi
KSKazuhiko Sawada
Kazuhiko Sawada
MKM. Kashima
M. Kashima
HSH. Sakata-Haga
H. Sakata-Haga
KFK. Fukuzaki
K. Fukuzaki
YFY. Fukui
Y. Fukui

1 September 2002 in Acta Neuropathologica
Verified
Journal Article
Closed access
PDF file
HSHiromi Sakata-Haga
Hiromi Sakata-Haga
KSKazuhiko Sawada
Kazuhiko Sawada
SHSetsuji Hisano
Setsuji Hisano
YFYoshihiro Fukui
Yoshihiro Fukui

18 December 2013 in The Anatomical Record
Verified
Journal Article
Closed access
PDF file
KSKazuhito Sakamoto
Kazuhito Sakamoto
KSKazuhiko Sawada
Kazuhiko Sawada
KFKatsuhiro Fukunishi
Katsuhiro Fukunishi
INImai Noritaka
Imai Noritaka
HSHiromi Sakata‐Haga
Hiromi Sakata‐Haga
FYFukui Yoshihiro
Fukui Yoshihiro

20 April 2021 in PLOS ONE
Verified
Journal Article
Open access
PDF file
KSKazuhiko Sawada
Kazuhiko Sawada
SKShiori Kamiya
Shiori Kamiya
IAIchio Aoki
Ichio Aoki
Valproic acid (VPA) treatment is associated with autism spectrum disorder in humans, and ferrets can be used as a model to test this; so far, it is not known whether ferrets react to developmental VPA exposure with gyrencephalic abnormalities. The current study characterized gyrification abnormalities in ferrets following VPA exposure during neonatal periods, corresponding to the late stage of cortical neurogenesis as well as the early stage of sulcogyrogenesis. Ferret pups received intraperitoneal VPA injections (200 μg/g of body weight) on postnatal days (PD) 6 and 7. BrdU was administered simultaneously at the last VPA injection. Ex vivo MRI-based morphometry demonstrated significantly lower gyrification index (GI) throughout the cortex in VPA-treated ferrets (1.265 ± 0.027) than in control ferrets (1.327 ± 0.018) on PD 20, when primary sulcogyrogenesis is complete. VPA-treated ferrets showed significantly smaller sulcal-GIs in the rostral suprasylvian sulcus and splenial sulcus but a larger lateral sulcus surface area than control ferrets. The floor cortex of the inner stratum of both the rostral suprasylvian and splenial sulci and the outer stratum of the lateral sulcus showed a relatively prominent expansion. Parvalbumin-positive neuron density was significantly greater in the expanded cortical strata of sulcal floors in VPA-treated ferrets, regardless of the BrdU-labeled status. Thus, VPA exposure during the late stage of cortical neurogenesis may alter gyrification, primarily in the frontal and parietotemporal cortical divisions. Altered gyrification may thicken the outer or inner stratum of the cerebral cortex by increasing parvalbumin-positive neuron density.